Dabur India Q3 FY26 Business Update: Mixed Performance Across Segments
Dabur India's Q3 FY26 business update shows mid-single digit consolidated revenue growth with mixed segment performance. While the HPC segment achieved double-digit growth and healthcare showed sequential improvement, the overall performance fell short of analyst expectations due to healthcare weakness and adverse seasonality in beverages. The company expects operating profit and PAT to grow ahead of revenue, with international business posting near double-digit growth in INR terms.

*this image is generated using AI for illustrative purposes only.
Dabur India has released its business update for Q3 FY26, revealing a mixed performance across different segments with mid-single digit consolidated revenue growth. The company indicated that operating profit and profit after tax are expected to grow ahead of revenue, suggesting improved operational efficiency during the quarter.
Segment-wise Performance Analysis
The India business showed varied performance across different categories during Q3 FY26:
| Segment | Performance | Growth Rate |
|---|---|---|
| HPC (India) | Strong performance | Double-digit growth |
| Healthcare | Sequential improvement | Low-single digit growth |
| International Business | Robust growth | Near double-digit (INR terms) |
The Home and Personal Care segment emerged as the standout performer with double-digit revenue growth, while the healthcare segment showed signs of recovery with sequential improvement in its growth trajectory, though still reporting low-single digit growth.
Market Expectations vs. Reality
Analyst expectations had been set higher for the quarter, with projections of 8.00% sales growth in Q3 FY26. The estimates factored in several positive elements including the impact of GST rate cuts, price hikes, and favorable base effects. However, Dabur's actual performance appears to have fallen short of these projections.
The underperformance has been attributed to specific challenges in certain categories:
- Weakness in the healthcare segment
- Adverse seasonality affecting the beverages category
- Overall growth at the lower end of the company's guidance range
Financial Guidance and Outlook
| Parameter | Details |
|---|---|
| H2 FY26 Guidance | Mid-to-high single digit revenue growth |
| Q3 FY26 Achievement | Lower end of guidance range |
| Operating Profit | Growth ahead of sales growth |
| Profit After Tax | Expected to grow ahead of revenue |
Dabur had previously guided for mid-to-high single digit revenue growth in H2 FY26, and the Q3 performance indicates achievement at the lower end of this guidance range. Despite revenue challenges, the company mentioned that operating profit growth has outpaced sales growth, indicating margin expansion efforts.
Risk Factors and Future Considerations
Several factors could influence Dabur's future performance trajectory. Upside risks include stronger-than-expected rural demand recovery and improved sales growth in currently lagging categories such as hair oil and beverages. Additionally, a favorable resolution of the Namaste litigation could provide positive momentum.
Conversely, downside risks center around sustained weakness in key categories including hair oil, health supplements, and beverages, which could continue to impact overall growth momentum in subsequent quarters.
Historical Stock Returns for Dabur India
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.28% | +3.15% | +1.83% | +1.31% | +2.08% | -2.94% |
















































